Compare Abeona Therapeutics Inc (ABEO) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Veritone Inc — how do they compare? Abeona Therapeutics Inc trades at $7.42 (market cap $421.19M), while Veritone Inc trades at $1.46 (market cap $138.04M). The key difference: Abeona Therapeutics Inc is far larger — about 3.1× Veritone Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | VERI | |
|---|---|---|
Market Cap | $421.19M | $138.04M |
Sector | Health | Technology |
52-Week High | $7.45 | $8.39 |
52-Week Low | $4.17 | $1.00 |
Enterprise Value | $276.10M | $170.07M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
